Patients receiving brentuximab vedotin plus chemotherapy demonstrated a significant improvement in overall survival at 6 years compared with those on standard chemotherapy.
Professional organizations and individuals are rallying to help Ukrainian colleagues, including one psychiatrist who drove his own vehicle filled with supplies ― and a much-needed ultrasound.